Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, Mfd. for Sanofi-Aventis, U.S., LLC, Bridgewater, NJ 08807, NDC 0068-0510-30
Published August 14, 2013 · Recall initiated: March 7, 2013
Summary
FDA records drug Class II recall D-841-2013, published August 14, 2013 and initiated March 7, 2013. Recalling firm: Sanofi US; Status: Terminated; Reported quantity: 2,462 bottles; Lot: Lot # 3097657, Exp 3/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent drug: low fill volume in some of the capsules
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Sanofi US
- Distributor
- Nationwide
- Lot
- Lot # 3097657, Exp 3/15
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZenecaAugust 14, 2013
- FDATerazosin Hydrochloride Capsules,10 mg, 100-count bottle, Rx only, Manufactured for Teva Pharmaceuticals USA,August 14, 2013
- FDAVersaPharm Incorporated, Ethambutol Hydrochloride Tablets, USP 400 mg 60 tablets, Rx Only, Mfd. for VersaPharmAugust 14, 2013
- FDAExcedrin Extra Strength (Acetaminophen 250 mg, Aspirin (NSAID) 250 mg and Caffeine 65 mg), a) 2-ct tablets inAugust 14, 2013
- FDAWarfarin Sodium Tablets, USP 2 mg, Rx Only, 1000 Tablets per bottle, Manufactured by: Cadila Healthcare LtdAugust 14, 2013
- FDAExcedrin Migraine (Acetaminophen 250 mg, Aspirin (NSAID) 250 mg and Caffeine 65 mg), a) 2-count tabletsAugust 14, 2013
Questions about this recall
Was Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, Mfd. for Sanofi-Aventis, U.S., LLC, Bridgewater, NJ 08807, NDC 0068-0510-30 recalled?
Yes. FDA published recall D-841-2013 on August 14, 2013. Reported hazard: Subpotent drug: low fill volume in some of the capsules
What should I do if I have this product?
Voluntary: Firm initiated · Letter